Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pharmaceutical Drug Delivery Market, by Route of Administration
1.4.2 Europe Pharmaceutical Drug Delivery Market, by Application
1.4.3 Europe Pharmaceutical Drug Delivery Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.2.5 Trials & Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2021-2024)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2021, Aug – 2023, Oct) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. Europe Pharmaceutical Drug Delivery Market, by Route of Administration
5.1 Europe Injectable Drug Delivery Market, by Country
5.2 Europe Oral Drug Delivery Market, by Country
5.3 Europe Topical Drug Delivery Market, by Country
5.4 Europe Nasal Drug Delivery Market, by Country
5.5 Europe Ocular Drug Delivery Market, by Country
Chapter 6. Europe Pharmaceutical Drug Delivery Market, by Application
6.1 Europe Respiratory & Other Diseases Market, by Country
6.2 Europe Cancer Market, by Country
6.3 Europe Diabetes Market, by Country
6.4 Europe Cardiovascular Diseases Market, by Country
Chapter 7. Europe Pharmaceutical Drug Delivery Market, by Country
7.1 Germany Pharmaceutical Drug Delivery Market
7.1.1 Germany Pharmaceutical Drug Delivery Market, by Route of Administration
7.1.2 Germany Pharmaceutical Drug Delivery Market, by Application
7.2 UK Pharmaceutical Drug Delivery Market
7.2.1 UK Pharmaceutical Drug Delivery Market, by Route of Administration
7.2.2 UK Pharmaceutical Drug Delivery Market, by Application
7.3 France Pharmaceutical Drug Delivery Market
7.3.1 France Pharmaceutical Drug Delivery Market, by Route of Administration
7.3.2 France Pharmaceutical Drug Delivery Market, by Application
7.4 Russia Pharmaceutical Drug Delivery Market
7.4.1 Russia Pharmaceutical Drug Delivery Market, by Route of Administration
7.4.2 Russia Pharmaceutical Drug Delivery Market, by Application
7.5 Spain Pharmaceutical Drug Delivery Market
7.5.1 Spain Pharmaceutical Drug Delivery Market, by Route of Administration
7.5.2 Spain Pharmaceutical Drug Delivery Market, by Application
7.6 Italy Pharmaceutical Drug Delivery Market
7.6.1 Italy Pharmaceutical Drug Delivery Market, by Route of Administration
7.6.2 Italy Pharmaceutical Drug Delivery Market, by Application
7.7 Rest of Europe Pharmaceutical Drug Delivery Market
7.7.1 Rest of Europe Pharmaceutical Drug Delivery Market, by Route of Administration
7.7.2 Rest of Europe Pharmaceutical Drug Delivery Market, by Application
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Trials & Approvals:
8.2.6 SWOT Analysis
8.3 Bayer AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Geographical Expansions:
8.3.6 SWOT Analysis
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.6 SWOT Analysis
8.5 Johnson & Johnson
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental & Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Novartis AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Amgen, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 Cipla Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.6 SWOT Analysis
Unique Offerings 